-
Icatibant, sold
under the
brand name Firazyr, is a
medication for the
symptomatic treatment of
acute attacks of
hereditary angioedema (HAE) in adults...
- with bradykinin-related
disease a C1
esterase inhibitor, ecallantide, or
icatibant may be used.
Fresh frozen plasma may be used instead. In the
United States...
- can be used for both
prevention and treatment,
while ecallantide and
icatibant can be used to
treat acute attacks. HAE
affects approximately 1 in 50...
-
private financing to date.[citation needed] Jerini's lead
compound Firazyr (
icatibant), is an
inhibitor of the
action of the
hormone bradykinin on its B2 receptor...
- disease, the
first in 2009: Cinryze, Berinert,
ecallantide (Kalbitor),
icatibant (Firazyr) and Ruconest.
Stanozolol is
still used long-term to
reduce the...
- are
being developed as
potential therapies for
hereditary angioedema.
Icatibant is one such inhibitor.
Additional bradykinin inhibitors exist. It has...
-
Sigurd (March 2011). "Rapid
resolution of
erythema marginatum after icatibant in
acquired angioedema". Acta dermato-venereologica. 91 (2): 185–186....
-
combinations B06AB01
Hemin B06AC01 C1-inhibitor,
plasma derived B06AC02
Icatibant B06AC03
Ecallantide B06AC04
Conestat alfa B06AC05
Lanadelumab B06AC06...
- (INN)
ibutamoren (INN)
ibuterol (INN)
ibutilide (INN)
ibuverine (INN)
icatibant (INN)
iclaprim (INN)
iclazepam (INN)
Iclusig icodextin (USAN) icoduline...
- wall
synthesis inhibitor vancomycin (which
caused Red Man syndrome),
icatibant, leuprolide, and morphine. MAS1
oncogene Pseudoallergy GRCh38: Ensembl...
